Found 73 matching trials
Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
PHASE3The purpose of this study is to complete the total safety database size for...
Location
GSK Investigational Site
Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants
PHASE3The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Location
GSK Investigational Site
To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants
PHASE3This study is planned to evaluate the safety (in terms of occurrence of any...
Location
GSK Investigational Site
The Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)
PHASE1The Phase I clinical trial of the oral hexavalent reassortant rotavirus att...
Location
Hebei Provincial Center for Disease Control and Prevention
Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants
PHASE1It has been observed that in children who get a severe rotavirus infection,...
Location
Society for Applied Studies
A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
PHASE3This is a Phase 3 multicentre, randomized, double blind, placebo-controlled...
Location
Dr Dinesh Kumar Government Medical College, Jammu Department of Community Medicine, Government Medical College
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants
N/AThis protocol posting deals with objectives and outcome measures of the pri...
Location
GSK Investigational Site
Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand
PHASE3Primary Objective:
To demonstrate the non-inferiority of the SHAN6™ vaccin...
Location
Investigational Site Number 7640003
Treatments Being Tested
DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus)DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b)Inactivated Poliomyelitis VaccinePoliomyelitis Vaccine bivalent types 1 and 3Human Rotavirus, live attenuatedPneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh
PHASE2The main objective of this study is to provide immunogenicity data for GSK ...
Location
GSK Investigational Site
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
PHASE1A double blind placebo controlled Phase I/II study to evaluate the safety a...
Location
Christian Medical College